Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections.
In a randomized prospective study, 66 patients with serious bacterial infections--mainly lower respiratory tract infections--were treated with either imipenem plus cilastatin (32 patients) or ciprofloxacin (34 patients); 30 patients in each group were evaluable for efficacy. Substantial underlying d...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1987
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174977/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3324956/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.10.1491 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|